Dr. Jan Fritz, a musculoskeletal radiologist, has joined the Medical Advisory Board of SyntheticMR and will support the company in its strategic initiatives and provide valuable clinical expertise.
Dr. Fritz, associate professor, and the division chief of Musculoskeletal Radiology at the NYU Grossman School of Medicine in New York City, will provide the Linköping, Sweden-based company with critical expertise and a background that includes over 170 peer-reviewed scientific articles, reviews, and book chapters.
“We have conducted research with quantitative SyntheticMR solutions over the past years and found multiple beneficial musculoskeletal applications,” says Dr. Fritz. “I am looking forward to working with the SyntheticMR team on developing and further refining musculoskeletal MRI applications and integrating the advantages of quantitative MRI into clinical practice.”
“The team at SyntheticMR are pleased to welcome Dr. Fritz to our Medical Advisory Board,” says Ulrik Harrysson, company CEO. “We pride ourselves in developing imaging solutions with high clinical value, and our users’ input are vital in this process. Dr Fritz’ expertise will be key as we look to expand and further develop our product offering in the future.”
Where else can SyntheticMR take us?
Dr. Fritz told OTW, “I will join the team to evaluate and expand the applications of the SyntheticMR techniques to the musculoskeletal system, focusing on the creation of clinical protocols that combine improved scan efficiency and morphological and quantitative biochemical evaluation of tissues, such as articular cartilage.”
“While SyntheticMR techniques in general have been focusing on the knee, there are many more promising applications in the musculoskeletal system, including the ankle, shoulder, elbow and wrist joints, as well as more challenging joints, including the hips and sacroiliac joints. SyntheticMR also holds promise for improved MRI acquisitions of the spine. In addition to the creation of additional clinical applications and practical MRI protocols, my role will include to guide research efforts and the scientific evaluations and descriptions of the new clinical applications.”
